Three-dimensional (3D) cancer models have emerged as pivotal tools in oncology research, offering a more accurate representation of tumor biology compared ...

SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a ...

The collaboration aims to enable researchers to easily adapt workflows to their applications while improving efficiency and ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Heterogeneous Hippo pathway (YAP/TAZ) activation in lung adenocarcinoma drives tumor progression by enabling ferroptosis ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is characterized by a high rate of metastasis ...

Cero will use Invivoscribe's multiparametric flow cytometry assay to detect minimal residual disease in patients and evaluate the therapy's efficacy.

The results show that a quantitative assay of the number of murine lymphoma cells capable of proliferating in vivo is, indeed, possible.